VANDA PHARMACEUTICALS ANNOUNCES FIRST PATIENT DOSED IN A TRIAL EVALUATING VCA-894A IN CHARCOT-MARIE-TOOTH DISEASE TYPE 2S

Reuters · 5d ago

Please log in to view news